Community Based Prevention of Rotavirus Gastroenteritis by a Functional Food Supplement

Phase 2

Completed

• Conditions: Rotavirus Gastroenteritis
• Interventions: Dietary Supplement: Maltodextrin; Dietary Supplement: Anti-rotavirus protein

• Registration Number: NCT01265355
• Lead Sponsor: Christian Medical College, Vellore, India

Brief Summary

Rotavirus is the commonest cause of severe gastroenteritis in young children worldwide. The investigators hypothesize that use of a food based prophylactic will decrease incidence of rotavirus infection in young children in south India, prevent intestinal damage and overall result in lower infection rates and better gut function. This trial will evaluate the efficacy of prevention of rotavirus gastroenteritis when an anti-rotavirus protein or antibody fragments expressed in yeast or placebo are given daily as a food supplement to children between the ages of 6 and 12 months. The children will followed for one year and rates of rotavirus diarrhoea, antibody responses and gut function will be compared between children receiving antibody fragments or placebo.

Detailed Description

The study will be carried out in an urban slum area in Vellore, south India. Children between the ages of 6 and 12 months will be recruited for participation in the study. They will be randomized to receive supplementation with ARP or placebo, and will be followed for a period of one year, with weekly home visits and monitoring of all episodes of diarrhoea. In addition, every two weeks, surveillance stool samples will be collected and tested for rotavirus to identify asymptomatic infections by PCR. All episodes of diarrhoea will be investigated intensively for bacterial, viral and parasitic agents of diarrhoea using both conventional and molecular techniques and all cases will be treated appropriately at the study clinic or referral hospital as required. Monthly anthropometric measurements will be carried out to estimate rates of growth and to identify growth faltering. Blood samples will be taken at 4, 8 and 12 months for estimation of anti-rotavirus IgA and IgG antibodies. Studies on intestinal absorption and permeability will be carried out at recruitment, 6 and 12 months by the lactulose:mannitol test (measured by HPLC detection of sugars). All rotavirus strains obtained will be characterized by genotyping.

Study Timeline

• Study First Submitted: 2010-12-21
• Study First Submitted QC: 2010-12-22
• Study First Posted: 2010-12-23
• Study Start: 2011-03
• Primary Completion: 2012-06
• Study Completion: 2012-06
• Status Verified: 2015-02
• Last Update Submitted: 2015-02-03
• Last Update Posted: 2015-02-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 330

Inclusion Criteria

• Healthy child aged 6 to 12 months, families resident in the study area, willing to participate and available for follow up for a period of one year
• Normal birth weight (> 2.5 kg), child exclusively breast fed for at least four months

Exclusion Criteria

• Families not available for a follow up period of one year
• Children with any atopic conditions
• Children with gross congenital anomalies including cardiovascular, renal or hepatic disease
• Children with syndromic or serological evidence of HIV infection

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Maltodextrin	Maltodextrin	-
Anti-rotavirus protein	Anti-rotavirus protein	-

Primary Outcome Measures

Name	Time	Method
Incidence of rotavirus gastroenteritis	One year after recruitment

Secondary Outcome Measures

Name	Time	Method
Weight For Height Z Score	At 6 and 12 months after recruitment
Characterization of strains causing rotavirus gastroenteritis	Over 12 months
Incidence of adverse events	Over 12 months
IgA And IgG Antibody Response To Rotavirus	At 4, 8 And 12 Months after recruitment
Intestinal Function by lactulose:mannitol	at 3, 6, 9 and 12 months

Trial Locations

Locations (1)

Christian Medical College; 🇮🇳 Vellore, TN, India